HEPION PHARMACEUTICALS, INC. (CTRVP) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading CTRVP…

HEPION PHARMACEUTICALS, INC. (CTRVP) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

HEPION PHARMACEUTICALS, INC.

CTRVP · CIK 1583771

4 · Aug 21, 2026 · Director, Interim CEO Stetz Gary S. was granted 1.35M Stock Options

4

Director, Interim CEO Stetz Gary S. was granted 1.35M Stock Options

Filed: Aug 21, 2026
Period: Aug 19, 2026
Accession: 0001493152-26-039705
Filer: Hepion Pharmaceuticals, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov